Evaluation of the clinical staging of esophageal cancer by using diffusion-weighted imaging

Experimental and Therapeutic Medicine

Volumn 1, Issue 5, 2010, Pages 847-851

  Aoyagi, Tomoyoshi ^a   Shuto, Kiyohiko ^a   Okazumi, Shinichi ^a   Shimada, Hideaki ^a   Nabeya, Yoshihiro ^a   Kazama, Toshiki ^a   Matsubara, Hisahiro ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Apparent diffusion coefficient; Diffusion weighted image; Esophageal cancer; Magnetic resonance imaging

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; FLUORODEOXYGLUCOSE F 18; SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; POSITRON EMISSION TOMOGRAPHY; TUMOR VOLUME; WHOLE BODY SCANNER;

EID: 77955210890     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.112     Document Type: Article

References (28)

1. Mori S and Barker PB: Diffusion magnetic resonance imaging: its principle and applications. Anat Rec 257: 102-109, 1999.
2. Butts K, Riederer SJ, Ehman RL, Felmlee JP and Grimm RC: Echo-planar imaging of the liver with a standard MR imaging system. Radiology 189: 259-264, 1993.
3. Edelman RR, Wielopolski P and Schmitt F: Echo-planar MR imaging. Radiology 192: 600-612, 1994.
4. Muller MF, Prasad P, Siewert B, Nissenbaum MA, RaptopoulosV and Edelman RR: Abdominal diffusion mapping with use of a whole-body echo-planar system. Radiology 190: 475-478, 1994.
5. Keogan MT and Edelman RR: Technologic advances in abdominal MR imaging. Radiology 220: 310-320, 2001.
6. Folpe AL, Lyles RH, Sprouse JT, Conrad EU III and Eary JF: (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 6: 1279-1287, 2000.
7. Sobin LH and Fleming ID: TNM Classification of Malignant Tumors, 5th edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80: 1803-1804, 1997.
8. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S and vanCauteren M: Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, stir and high resolution 3D display. Radiat Med 22: 275-282, 2004.
9. Eo S and Je T: Spin diffusion measurements: spin echoes in the presence of time-dependent field gradients. J Chem Phys 42: 288-292, 1965.
10. De Vries A, Griebel J, Kremser C, et al: Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy. Radiology 217: 385-391, 2000.
11. Hayashida Y, Hirai T, Morishita S, et al: Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol 27: 1419-1425, 2006.
12. Mardor Y, Pfeffer R, Spiegelmann R, et al: Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 21: 1094-1100, 2003.
13. Asao C, Korogi Y, Kitajima M, et al: Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol 26: 1455-1460, 2005.
14. Yang D, Korogi Y, Sugahara T, et al: Cerebral gliomas: Prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 44: 656-666, 2002.
15. Tien RD, Felsberg GJ, Friedman H, Brown M and MacFall J: MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol 162: 671-677, 1994.
16. Sugahara T, Korogi Y, Kochi M, et al: Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9: 53-60, 1999.
17. Dzik-Jurasz A, Domenig C, George M, et al: Diffusion MRI for prediction of response of rectal cancer to chemo radiation. Lancet 360: 307-308, 2002.
18. Hein PA, Kremser C, Judmaier W, et al: Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 45: 214-222, 2003.
19. Kremser C, Judmaier W, Hein P, Griebel J, Lukas P and deVriesA: Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol 179: 641-649, 2003.
20. Sakurada ATT, Kwee TC, Yamashita T, Nasu S, Horie T, vanCauteren M and Imai Y: Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer. Eur Radiol 19: 1461-1469, 2009.
21. Gideon P, Sorensen PS, Thomsen C, Stahlberg F, Gjerris F and Henriksen O: Increased brain water self-diffusion in patients with idiopathic intracranial hypertension. AJNR Am J Neuroradiol 16: 381-387, 1995.
22. Szafer A, Zhong J and Gore JC: Theoretical model for water diffusion in tissues. Magn Reson Med 33: 697-712, 1995.
23. Duong TQ, Ackerman JJ, Ying HS and Neil JJ: Evaluation of extra- and intracellular apparent diffusion in normal and globally ischemic rat brain via 19F NMR. Magn Reson Med 40: 1-13, 1998.
24. Haberkorn U, Strauss LG, Reisser C, et al: Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med 32: 1548-1555, 1991.
25. Jacob R, Welkoborsky HJ, Mann WJ, Jauch M and Amedee R: [Fluorine-18]fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck. ORLJ Otorhinolaryngol Relat Spec 63: 307-313, 2001.
26. Kitagawa Y, Sano K, Nishizawa S, et al: FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 30: 63-71, 2003.
27. Minn H, Joensuu H, Ahonen A and Klemi P: Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer 61: 1776-1781, 1988.
28. Shimada H, Nabeya Y, Okazumi S, et al: Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Surgery 133: 486-494, 2003.